Norovirus Infections Clinical Trial
Official title:
A Pilot Study of Enteral Donor Human Milk in Young Children With Norovirus Infection of the Gut
Human Breast milk in young children with Norovirus Infection
The investigators hypothesize that children with clinically significant norovirus infection of the gut who receive enteral human milk will more successfully clear the virus or experience improved symptoms compared to children not receiving human milk. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04188691 -
A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine
|
Phase 1 | |
| Recruiting |
NCT04941261 -
Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)
|
Phase 2 | |
| Not yet recruiting |
NCT05916326 -
Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha)
|
Phase 3 | |
| Completed |
NCT05212168 -
Norovirus Challenge Study
|
Phase 1/Phase 2 | |
| Completed |
NCT05213728 -
A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers
|
Phase 1 | |
| Completed |
NCT06211621 -
Admission Pattern Among Children With Gastro-intestinal Infections Before and During the Covid-19 Pandemic
|
||
| Active, not recruiting |
NCT05626803 -
A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers
|
Phase 2 | |
| Completed |
NCT01435811 -
Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)
|
Phase 1 | |
| Completed |
NCT04875676 -
Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines
|
Phase 1/Phase 2 | |
| Completed |
NCT04854746 -
Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine
|
Phase 1 |